Skip to main content
    C

    cbdMD Inc (YCBD)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • AMEX

    $0.34
    -0.01 (-3.94%)

    Market Cap: $3.96M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    30%(9/30)
    Avg Surprise
    -178.34%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.20
    Range$-0.20 - $-0.20
    1 analysts
    Revenue Consensus
    $6M
    Range$6M - $6M
    1 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.06
    Range$-0.06 - $-0.06
    1 analysts
    EPS Revisions
    1
    0
    7d
    No revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago$0.00n/a
    30d ago$0.00n/a
    7d ago$-0.10+40.0%
    Current$-0.06
    Revenue Consensus
    $6M
    Range$6M - $6M
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.06---
    Sep 26EST
    		-$-0.20---
    Jun 26
    Reported Aug 13
    		$-0.11$-0.03-266.67%Miss+47.6%
    Mar 26
    Reported May 14
    		$-0.08$-0.05-60.00%Miss+95.8%
    Dec 25
    Reported Feb 17
    		$-0.04$-0.06+33.33%Beat+97.7%
    Sep 25
    Reported Dec 19
    		$-0.08$-0.07-14.29%Miss+72.7%
    Jun 25
    Reported Aug 14
    		$-0.21$-0.16-31.25%Miss+82.5%
    Mar 25
    Reported May 15
    		$-1.90$-1.60-18.75%Miss+82.4%
    Dec 24
    Reported Feb 13
    		$-1.76$-2.96+40.54%Beat+66.2%
    Sep 24
    Reported Dec 27
    		$-0.29$-0.45+34.82%Beat+75.8%
    Jun 24
    Reported Aug 14
    		$-1.20N/A+75.81%Beat+87.1%
    Mar 24
    Reported May 15
    		$-10.80$-6.00-80.00%Miss-35900.0%
    Dec 23
    Reported Jan 29
    		$-5.21$-5.92+11.99%Beat+81.9%
    Sep 23
    Reported Dec 22
    		$-1.21$-0.76-59.21%Miss-369.5%
    Jun 23
    Reported Aug 10
    		$-9.28N/A+67.78%Beat+95.3%
    Mar 23
    Reported May 15
    		$-0.03$-0.04+25.00%Beat+99.9%
    Dec 22
    Reported Feb 13
    		$-28.80N/A+77.14%Beat+77.1%
    Sep 22
    Reported Dec 15
    		$-0.26$-0.03-759.00%Miss-268.1%
    Jun 22
    Reported Aug 11
    		$-198.00$-18.00-1000.00%Miss-370.1%
    Mar 22
    Reported May 13
    		$-36.00$-14.40-150.00%Miss-27.2%
    Dec 21
    Reported Feb 10
    		$-126.00$-14.40-775.00%Miss-1086.4%
    Sep 21
    Reported Dec 17
    		$-0.07$-0.04-75.00%Miss+50.0%
    Jun 21
    Reported Aug 12
    		$-42.12$-21.60-95.00%Miss-319.5%
    Mar 21
    Reported May 12
    		$-28.30$-14.40-96.53%Miss+49.3%
    Dec 20
    Reported Feb 9
    		$-10.62$-3.60-195.00%Miss+79.2%
    Sep 20
    Reported Dec 22
    		$-0.14$-0.01-1300.00%Miss-117.7%
    Jun 20
    Reported Aug 12
    		$-10.04$-9.00-11.56%Miss+97.7%
    Mar 20
    Reported May 18
    		$-55.87$-25.20-121.71%Miss-79.6%
    Dec 19
    Reported Feb 13
    		$-51.05$-46.62-9.50%Miss-84983.3%
    Sep 19
    Reported Dec 18
    		$0.79$-0.17+564.71%Beat+890.0%
    Jun 19
    Reported Aug 14
    		$-428.40$-36.00-1090.00%Miss-1428100.0%
    Mar 19
    Reported May 15
    		$-31.10$-18.00-72.78%Miss-18394.1%
    Dec 18
    Reported Feb 14
    		$-0.06N/AN/ABeat+64.7%
    Sep 18
    Reported Dec 12
    		$-0.10N/AN/ABeat-233.3%
    Jun 18
    Reported Aug 14
    		$0.03N/AN/ABeat+123.1%
    Mar 18
    Reported May 15
    		$0.17N/AN/ABeat-
    Dec 17
    Reported Feb 14
    		$-0.17N/AN/ABeat-
    Sep 17
    Reported Dec 26
    		$-0.03$0.00N/AMiss-
    Mar 17
    Reported May 4
    		$-0.13$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-1.10EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin-13.80%Operating Margin-20.40%
    ROE-40.30%ROICN/A
    Financial Health
    Debt/Equity0.23xInterest CoverageN/A
    Current Ratio2.50xQuick Ratio1.37x
    Trading Statistics
    Beta2.25Avg Volume833.47K
    52-Week High$2.5652-Week Low$0.33

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.40
    SMA 20$0.43
    SMA 50$0.48
    SMA 200$0.71
    EMA 10$0.39
    EMA 20$0.42
    EMA 50$0.48
    EMA 200$0.69

    MACD

    Line: -0.04Signal: -0.03Hist: -0.01

    ADX

    ADX: 23.5+DI: 13.2-DI: 27.8

    Aroon & PSAR

    Aroon Up28.0
    Aroon Down96.0
    PSAR$0.43

    Bollinger Bands

    Upper Band$0.52
    Lower Band$0.34
    %B Position4263%(Upper)
    Band Width0.00

    RSI (14-Day)

    Oversold
    25.6

    Momentum Oscillators

    Stoch %K8.5
    Stoch %D8.0
    Williams %R-92.2
    ROC (10d)-24.7%
    Momentum-0.11
    CCI (20d)-157.0
    MFI (14d)11.1

    Volatility Measures

    ATR (14d)$0.03(9.8%)
    StdDev (20d)0.05
    Hist Vol85.9%(High)

    Volume Flow

    VWAP$0.35
    OBV622.5M
    AD Line796.1M
    CMF (20d)-0.288

    Volume Metrics

    Avg Vol (20d)908.8K
    Vol Ratio0.1x(Low)
    VWMA (20d)$0.45

    Pivot Points

    R3$0.40
    R2$0.38
    R1$0.37
    Pivot Point$0.35
    S1$0.34
    S2$0.32
    S3$0.30

    Advanced Oscillators

    TSI-31.45
    Ultimate Osc36.7
    KST-164.98

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$5.55M$5.64M$5.02M$4.72M$4.61M$4.75M$5.11M$4.56M$5.17M$4.38M$5.38M$5.71M
    Cost of Revenue$2.52M$2.38M$2.02M$1.94M$1.78M$1.79M$1.71M$2.10M$1.77M$1.80M$1.82M$2.16M
    Gross Profit$3.04M$3.26M$3.00M$2.78M$2.83M$2.96M$3.40M$2.45M$3.40M$2.58M$3.56M$3.55M
    Operating Expenses$4.17M$4.06M$3.29M$3.46M$3.74M$3.45M$3.49M$2.78M$3.79M$4.13M$4.62M$18.58M
    R&D$0$0$808$0$0$0$0$0$0$0$0$0
    SG&A$0$0$1.69M$0$0$0$0$0$0$0$0$0
    Operating Income$-1,130,477$-800,784$-286,288$-685,816$-904,686$-485,816$-86,272$-316,556$-382,028$-1,550,991$-1,065,835$-15,217,072
    Interest Income$0$0$3,157$0$0$0$0$0$0$0$0$0
    Interest Expense$-3,275$-2,806$0$-5,848$-9,414$-7,642$-11,404$-2,051$12,741$18,399$418$-37,775
    Income Before Tax$-1,127,202$-797,978$-283,131$-679,968$-895,272$-480,757$15,095$-152,800$459,737$-3,010,562$-996,501$-15,874,941
    Income Tax Expense$0$0$41.47M$0$0$0$0$0$0$0$0$0
    Net Income$-1,127,202$-797,978$-283,131$-679,968$-895,272$-480,757$15,095$-152,800$459,737$-3,010,562$-996,501$-15,874,941
    EBITDA$-689,359$-800,784$133,499$-253,279$-456,173$87,335$130,342$-74,018$1.06M$-2,412,283$-421,918$-15,143,508
    EBIT$-1,130,477$-800,784$-283,131$-685,816$-904,686$-488,399$-286,288$-150,023$472,478$-2,996,991$-996,083$-16,098,355
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about YCBD

    News

    Cbdmd Inc (YCBD-A) Stock Price and News

    This article provides current stock information for cbdMD Inc. (YCBD-A), including real-time quotes, recent news, and company profile. It highlights recent analyst opinions, acquisition news, financial reports...

    The Globe and Mail•10/1/26•Neutral

    cbdMD, Inc. Share Price Live Today – AMEX:YCBD Stock Price, Chart, News, History

    As of October 1, 2026, cbdMD, Inc. (AMEX: YCBD) shares are trading at $0.46, reflecting a 37.71% decline over the last six months and a 62.57% year-on-year drop. The company, which owns cbdMD, Paw CBD, and ATRx Labs...

    Upstox•9/30/26•Bearish

    Why Is cbdMD (NYSE American:YCBD) Buying Twinlab Brand Assets?

    cbdMD (NYSE American:YCBD) has entered into an agreement to acquire Twinlab brand assets, aiming to diversify its product offerings beyond CBD and hemp-derived products into traditional vitamins, minerals...

    Kalkine Media•9/24/26•Somewhat-Bullish

    CbdMD, Inc. entered into a definitive asset purchase agreement to acquire Operating assets and brands of Twinlab Consolidation Corporation for $2.9 million.

    CbdMD, Inc. has entered into a definitive asset purchase agreement to acquire the operating assets and brands of Twinlab Consolidation Corporation for $2.9 million. The consideration includes assuming approximately $1.75...

    marketscreener.com•9/3/26•Bullish

    cbdMD to Acquire Twinlab's Legacy Supplement Brands

    cbdMD has entered into a definitive agreement to acquire Twinlab's operating assets and brands, including Twinlab, Reserveage, Metabolife...

    Nutritional Outlook•9/3/26•Somewhat-Bullish

    YCBD Valuation and Fair Value

    P/E
    -1.1x
    Forward P/E
    714.3x
    P/B
    0.4x
    See GNG's fair value

    YCBD Profitability: Margins, ROIC and FCF

    Operating margin
    -20.4%
    Net margin
    -13.8%
    ROE
    -40.3%

    YCBD Competitors

    CompanyTicker
    Jupiter Neurosciences, Inc. Common StockJUNS
    PharmaCyte Biotech IncPMCB
    Azitra IncAZTR
    NanoVibronix IncNAOV
    Liminatus Pharma, Inc. Class A Common StockLIMN
    Akanda CorpAKAN
    Dermata Therapeutics IncDRMA
    Eterna Therapeutics IncERNA

    Sector: Healthcare

    YCBD Bull Case vs Bear Case

    Bull case

    • YCBD grew quarterly revenue 20.6% year over year.

    Bear case

    • YCBD has a -13.8% net profit margin.
    • YCBD beat EPS estimates in 37.5% of its last 8 reported quarters.

    YCBD Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -35.3%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.20

    Frequently Asked Questions About YCBD

    Does YCBD pay dividends?

    cbdMD Inc (YCBD) does not currently pay a regular dividend.

    What is YCBD's market cap?

    cbdMD Inc (YCBD) has a market capitalization of $3.96M with a current stock price of $0.34.

    Related stocks

    Sector: Healthcare

    All stocks starting with Y

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In